Clinical Trial Update: Zanubrutinib, Lenalidomide and Rituximab (ZR2) in Elderly Treatment-naive Patients With Diffuse Large B-cell Lymphoma (DLBCL) [Phase 2]

View source ↗

Summary

Phase 2 trial update for Zanubrutinib, Lenalidomide and Rituximab (ZR2) in elderly, treatment-naive Diffuse large B-cell lymphoma. The study is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• BRUKINSA (ZANUBRUTINIB)
• Revlimid (lenalidomide)
• Rituxan (rituximab)

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING